Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HALO BioSynthesis Laboratories

HALO BioSynthesis Laboratories
2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and distributor of Cannabidiol (CBD) products for clinical and natural health markets. The company specializes in CBD products and serves clients in the biotech, natural health and wellness industries, as well as the medical and retail marijuana e-liquid and edibles markets.

Website
Formerly Known As
Legacy Bio-Naturals
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 6100 219th Street Southwest
  • Suite 480
  • Mountlake Terrace, WA 98043
  • United States

+1 (360) 000-0000

HALO BioSynthesis Laboratories Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore HALO BioSynthesis Laboratories‘s full profile, request access.

Request full access to PitchBook

HALO BioSynthesis Laboratories Executive Team (2)

Name Title Board
Seat
Contact
Info
Susanne Posel Co-Founder

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »